Marvell's (MRVL) Q1 performance is likely to have been affected by weakness in its product demand as enterprises are postponing their large IT spending plans amid macroeconomic uncertainties.
Salesforce, Cava, Dell and Abercrombie & Fitch earnings loom but the core PCE price index, the Fed's favorite inflation gauge, highlights the week.
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?